Insider Trading & Ownership - Aerovate Therapeutics Inc. (AVTE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aerovate Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-11-07
Sale		 2022-11-09
5:00 pm		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 2,250 $19.2 $43,194 157,139
(Direct)		 View
2022-11-01
Sale		 2022-11-03
5:00 pm		 Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER		 1,038 $19.5 $20,241 0
(Direct)		 View
2022-11-02
Sale		 2022-11-03
5:00 pm		 Aerovate Therapeutics Inc. AVTE Verwijs Marinus
SENIOR VICE PRESIDENT, CMC		 1,130 $18.89 $21,346 0
(Direct)		 View
2022-10-18
Sale		 2022-10-20
5:00 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 5,705 $21.08 $120,287 299,166
(Direct)		 View
2022-10-14
Sale		 2022-10-18
5:01 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,295 $20.16 $86,585 613,927
(Direct)		 View
2022-10-10
Sale		 2022-10-12
5:00 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,954 $16.89 $83,681 309,166
(Direct)		 View
2022-10-06
Sale		 2022-10-11
5:00 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 23,560 $15.91 $374,803 716,045
(Direct)		 View
2022-10-05
Sale		 2022-10-07
5:00 pm		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 2,250 $15.75 $35,447 159,389
(Direct)		 View
2022-09-12
Sale		 2022-09-14
5:15 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 7,520 $17.33 $130,307 36,900
(Direct)		 View
2022-09-08
Sale		 2022-09-12
5:30 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 7,840 $17.8 $139,584 108,310
(Direct)		 View
2022-09-06
Sale		 2022-09-08
5:30 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 12,829 $18.5 $237,345 82,476
(Direct)		 View
2022-09-06
Sale		 2022-09-07
5:30 pm		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 2,250 $19 $42,750 161,639
(Direct)		 View
2022-08-18
Sale		 2022-08-19
5:00 pm		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 2,250 $21.18 $47,657 163,889
(Direct)		 View
2022-08-16
Sale		 2022-08-18
5:00 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 21,000 $23 $482,932 69,908
(Direct)		 View
2022-08-10
Sale		 2022-08-12
5:15 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 14,067 $24.07 $338,598 38,513
(Direct)		 View
2022-08-08
Sale		 2022-08-10
5:15 pm		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 15,643 $24.31 $380,287 74,000
(Direct)		 View
2021-07-02
Purchase		 2021-07-07
4:45 pm		 Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner		 500,000 $14 $7,000,000 2,030,691
(Indirect)		 View
2021-07-02
Purchase		 2021-07-06
5:03 pm		 Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner		 2,785,714 $14 $38,999,996 311,170
(Indirect)		 View
2021-07-02
Purchase		 2021-07-06
4:28 pm		 Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner		 357,142 $14 $4,999,988 3,758,686
(Direct)		 View
2021-07-02
Purchase		 2021-07-06
4:27 pm		 Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner		 357,142 $14 $4,999,988 3,761,153
(Indirect
Direct)		 View
2021-07-02
Purchase		 2021-07-06
4:27 pm		 Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director		 535,714 $14 $7,499,996 3,106,032
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-11-07
Exercise		 2022-11-09
5:00 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 2,250 $0 157,139
(Direct)		 View
2022-11-07
Exercise		 2022-11-09
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 1,600 $2.14 157,139
(Direct)		 View
2022-11-07
Exercise		 2022-11-09
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 650 $1.74 157,139
(Direct)		 View
2022-10-18
Exercise		 2022-10-20
5:00 pm		 N/A
2031-04-01		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 5,705 $0 299,166
(Direct)		 View
2022-10-18
Exercise		 2022-10-20
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 5,705 $2.14 299,166
(Direct)		 View
2022-10-14
Exercise		 2022-10-18
5:01 pm		 N/A
2031-04-01		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,295 $0 613,927
(Direct)		 View
2022-10-14
Exercise		 2022-10-18
5:01 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,295 $2.14 613,927
(Direct)		 View
2022-10-10
Exercise		 2022-10-12
5:00 pm		 N/A
2031-04-01		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,954 $0 309,166
(Direct)		 View
2022-10-10
Exercise		 2022-10-12
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 4,954 $2.14 309,166
(Direct)		 View
2022-10-06
Exercise		 2022-10-11
5:00 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 23,560 $0 716,045
(Direct)		 View
2022-10-06
Exercise		 2022-10-11
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 21,149 $2.14 716,045
(Direct)		 View
2022-10-06
Exercise		 2022-10-11
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 2,411 $1.74 716,045
(Direct)		 View
2022-10-05
Exercise		 2022-10-07
5:00 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 2,250 $0 159,389
(Direct)		 View
2022-10-05
Exercise		 2022-10-07
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 1,600 $2.14 159,389
(Direct)		 View
2022-10-05
Exercise		 2022-10-07
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
CHIEF SCIENTIFIC OFFICER		 650 $1.74 159,389
(Direct)		 View
2022-09-12
Exercise		 2022-09-14
5:15 pm		 N/A
2031-04-02		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 7,520 $0 36,900
(Direct)		 View
2022-09-12
Exercise		 2022-09-14
5:15 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
SEE REMARKS		 7,520 $2.14 36,900
(Direct)		 View
2022-09-08
Exercise		 2022-09-12
5:30 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 7,840 $0 108,310
(Direct)		 View
2022-09-09
Exercise		 2022-09-12
5:30 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 4,462 $2.14 108,310
(Direct)		 View
2022-09-08
Exercise		 2022-09-12
5:30 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 3,378 $1.74 108,310
(Direct)		 View
2022-09-06
Exercise		 2022-09-08
5:30 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 17,386 $0 82,476
(Direct)		 View
2022-09-06
Exercise		 2022-09-08
5:30 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 17,386 $1.74 82,476
(Direct)		 View
2022-09-06
Exercise		 2022-09-07
5:30 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 2,250 $0 161,639
(Direct)		 View
2022-09-06
Exercise		 2022-09-07
5:30 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 1,600 $2.14 161,639
(Direct)		 View
2022-09-06
Exercise		 2022-09-07
5:30 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 650 $1.74 161,639
(Direct)		 View
2022-08-18
Exercise		 2022-08-19
5:00 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 2,250 $0 163,889
(Direct)		 View
2022-08-18
Exercise		 2022-08-19
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 1,600 $2.14 163,889
(Direct)		 View
2022-08-18
Exercise		 2022-08-19
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Scientific Officer		 650 $1.74 163,889
(Direct)		 View
2022-08-16
Exercise		 2022-08-18
5:00 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 21,000 $0 69,908
(Direct)		 View
2022-08-16
Exercise		 2022-08-18
5:00 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 21,000 $1.74 69,908
(Direct)		 View
2022-08-10
Exercise		 2022-08-12
5:15 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 14,067 $0 38,513
(Direct)		 View
2022-08-10
Exercise		 2022-08-12
5:15 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 14,067 $1.74 38,513
(Direct)		 View
2022-08-08
Exercise		 2022-08-10
5:15 pm		 N/A
2030-09-03		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 15,643 $0 74,000
(Direct)		 View
2022-08-08
Exercise		 2022-08-10
5:15 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 15,643 $1.74 74,000
(Direct)		 View
2022-07-15
Other		 2022-07-19
5:28 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
10% Owner		 310,388 $0 2,638,297
(Direct)		 View
2022-06-21
Option Award		 2022-06-22
5:01 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE Dorval Allison
Director		 12,500 $0 12,500
(Direct)		 View
2022-06-21
Option Award		 2022-06-22
5:00 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE Iwicki Mark T
Director		 12,500 $0 12,500
(Direct)		 View
2022-06-21
Option Award		 2022-06-22
5:00 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE Resnick Joshua
Director		 12,500 $0 12,500
(Direct)		 View
2022-06-21
Option Award		 2022-06-22
5:00 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner		 12,500 $0 12,500
(Indirect)		 View
2022-06-21
Option Award		 2022-06-22
5:00 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director		 12,500 $0 12,500
(Direct)		 View
2022-06-21
Option Award		 2022-06-22
5:00 pm		 N/A
2032-06-20		 Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner		 12,500 $0 12,500
(Direct)		 View
2022-04-01
Other		 2022-04-04
5:13 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Atlas Venture Fund XII L.P.
10% Owner		 465,582 $0 3,103,879
(Direct)		 View
2022-03-21
Option Award		 2022-03-23
07:47 am		 N/A
2032-03-20		 Aerovate Therapeutics Inc. AVTE Verwijs Marinus
Senior Vice President, CMC		 90,000 $0 90,000
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
5:15 pm		 N/A
2032-01-02		 Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director		 7,317 $6.56 7,317
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
5:15 pm		 N/A
2032-01-02		 Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner		 7,240 $6.56 7,240
(Direct)		 View
2021-12-14
Option Award		 2021-12-16
6:00 pm		 N/A
2031-12-13		 Aerovate Therapeutics Inc. AVTE Dake Benjamin T
See Remarks		 58,000 $0 58,000
(Direct)		 View
2021-12-14
Option Award		 2021-12-16
6:00 pm		 N/A
2031-12-13		 Aerovate Therapeutics Inc. AVTE NOYES TIMOTHY P
Chief Executive Officer		 204,501 $0 204,501
(Direct)		 View
2021-12-14
Option Award		 2021-12-16
6:00 pm		 N/A
2031-12-13		 Aerovate Therapeutics Inc. AVTE Gillies Hunter
Chief Medical Officer		 65,433 $0 65,433
(Direct)		 View
2021-12-14
Option Award		 2021-12-16
6:00 pm		 N/A
2031-12-13		 Aerovate Therapeutics Inc. AVTE Eldridge George A
See Remarks		 65,433 $0 65,433
(Direct)		 View
2021-12-14
Option Award		 2021-12-16
6:00 pm		 N/A
2031-12-13		 Aerovate Therapeutics Inc. AVTE NIVEN RALPH
Chief Development Officer		 65,433 $0 65,433
(Direct)		 View
2021-07-15
Option Award		 2021-07-19
4:28 pm		 N/A
2031-07-14		 Aerovate Therapeutics Inc. AVTE Dorval Allison
Director		 25,000 $0 25,000
(Direct)		 View
2021-07-02
Conversion		 2021-07-07
4:45 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner		 1,530,691 $0 2,030,691
(Indirect)		 View
2021-07-02
Conversion		 2021-07-06
5:03 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner		 21,502,383 $0 311,170
(Indirect)		 View
2021-07-02
Conversion		 2021-07-06
4:28 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Sofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
HEALY JAMES
10% Owner		 13,966,782 $0 3,758,686
(Direct)		 View
2021-07-02
Conversion		 2021-07-06
4:27 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner		 13,966,782 $0 3,761,153
(Indirect)		 View
2021-07-01
Option Award		 2021-07-06
4:27 pm		 N/A
2031-06-30		 Aerovate Therapeutics Inc. AVTE Katabi Maha
Director
10% Owner		 2,467 $11.15 3,761,153
(Direct)		 View
2021-07-02
Conversion		 2021-07-06
4:27 pm		 N/A
N/A		 Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director		 10,544,919 $0 3,106,032
(Indirect)		 View
2021-07-01
Option Award		 2021-07-06
4:27 pm		 N/A
2031-06-30		 Aerovate Therapeutics Inc. AVTE GRAYZEL DAVID S.
Director		 2,153 $11.15 3,106,032
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, Next